Comparison of chromosomal status in reserved multiple displacement amplification products of embryos that resulted in miscarriages or live births: a blinded, nonselection case–control study

To analyze chromosomal status in reserved multiple displacement amplification (MDA) products of embryos that result in miscarriages or live births. Patients who underwent preimplantation genetic testing for monogenic disorders (PGT-Ms) without aneuploidy screening were included. The case group inclu...

Full description

Saved in:
Bibliographic Details
Published inBMC medical genomics Vol. 15; no. 1; pp. 35 - 8
Main Authors Yang, Guoxia, Xu, Yan, Zeng, Yanhong, Guo, Jing, Pan, Jiafu, Zhou, Canquan, Xu, Yanwen
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 23.02.2022
BioMed Central
BMC
Subjects
Online AccessGet full text
ISSN1755-8794
1755-8794
DOI10.1186/s12920-022-01187-y

Cover

Loading…
Abstract To analyze chromosomal status in reserved multiple displacement amplification (MDA) products of embryos that result in miscarriages or live births. Patients who underwent preimplantation genetic testing for monogenic disorders (PGT-Ms) without aneuploidy screening were included. The case group included 28 cycles that resulted in miscarriages. Controls included 56 cycles with live births. Comprehensive chromosomal screening (CCS) using next-generation sequencing (NGS) was performed on reserved MDA products from previous blastocyst trophectoderm biopsies. The incidence and type of chromosomal abnormalities in embryos resulting in miscarriages or live births were analyzed. Of 28 embryos resulting in miscarriages in the case group, the rate of chromosomal abnormalities was 53.6%, which was significantly greater than 14.3% for those resulting in live births in control group (P < 0.001). Whole-chromosome aneuploidy was not found in the control group but was noted in 25.0% of embryos in the case group. Although the rates of segmental abnormality and mosaicism were also greater in the case group, no significant differences were detected. One chaotic embryo in the control group progressed to live birth. Chromosomal abnormalities were the main reason leading to early pregnancy loss. However, abnormalities, such as segmental aneuploidy and mosaicism, should be managed cautiously, considering their undermined reproductive potential.
AbstractList Objective To analyze chromosomal status in reserved multiple displacement amplification (MDA) products of embryos that result in miscarriages or live births. Methods Patients who underwent preimplantation genetic testing for monogenic disorders (PGT-Ms) without aneuploidy screening were included. The case group included 28 cycles that resulted in miscarriages. Controls included 56 cycles with live births. Comprehensive chromosomal screening (CCS) using next-generation sequencing (NGS) was performed on reserved MDA products from previous blastocyst trophectoderm biopsies. The incidence and type of chromosomal abnormalities in embryos resulting in miscarriages or live births were analyzed. Results Of 28 embryos resulting in miscarriages in the case group, the rate of chromosomal abnormalities was 53.6%, which was significantly greater than 14.3% for those resulting in live births in control group (P < 0.001). Whole-chromosome aneuploidy was not found in the control group but was noted in 25.0% of embryos in the case group. Although the rates of segmental abnormality and mosaicism were also greater in the case group, no significant differences were detected. One chaotic embryo in the control group progressed to live birth. Conclusion Chromosomal abnormalities were the main reason leading to early pregnancy loss. However, abnormalities, such as segmental aneuploidy and mosaicism, should be managed cautiously, considering their undermined reproductive potential. Keywords: Chromosomal abnormalities, Preimplantation genetic testing for monogenic disorders (PGT-Ms), Preimplantation genetic testing for aneuploidy screening (PGT-A), Mosaicism
To analyze chromosomal status in reserved multiple displacement amplification (MDA) products of embryos that result in miscarriages or live births.OBJECTIVETo analyze chromosomal status in reserved multiple displacement amplification (MDA) products of embryos that result in miscarriages or live births.Patients who underwent preimplantation genetic testing for monogenic disorders (PGT-Ms) without aneuploidy screening were included. The case group included 28 cycles that resulted in miscarriages. Controls included 56 cycles with live births. Comprehensive chromosomal screening (CCS) using next-generation sequencing (NGS) was performed on reserved MDA products from previous blastocyst trophectoderm biopsies. The incidence and type of chromosomal abnormalities in embryos resulting in miscarriages or live births were analyzed.METHODSPatients who underwent preimplantation genetic testing for monogenic disorders (PGT-Ms) without aneuploidy screening were included. The case group included 28 cycles that resulted in miscarriages. Controls included 56 cycles with live births. Comprehensive chromosomal screening (CCS) using next-generation sequencing (NGS) was performed on reserved MDA products from previous blastocyst trophectoderm biopsies. The incidence and type of chromosomal abnormalities in embryos resulting in miscarriages or live births were analyzed.Of 28 embryos resulting in miscarriages in the case group, the rate of chromosomal abnormalities was 53.6%, which was significantly greater than 14.3% for those resulting in live births in control group (P < 0.001). Whole-chromosome aneuploidy was not found in the control group but was noted in 25.0% of embryos in the case group. Although the rates of segmental abnormality and mosaicism were also greater in the case group, no significant differences were detected. One chaotic embryo in the control group progressed to live birth.RESULTSOf 28 embryos resulting in miscarriages in the case group, the rate of chromosomal abnormalities was 53.6%, which was significantly greater than 14.3% for those resulting in live births in control group (P < 0.001). Whole-chromosome aneuploidy was not found in the control group but was noted in 25.0% of embryos in the case group. Although the rates of segmental abnormality and mosaicism were also greater in the case group, no significant differences were detected. One chaotic embryo in the control group progressed to live birth.Chromosomal abnormalities were the main reason leading to early pregnancy loss. However, abnormalities, such as segmental aneuploidy and mosaicism, should be managed cautiously, considering their undermined reproductive potential.CONCLUSIONChromosomal abnormalities were the main reason leading to early pregnancy loss. However, abnormalities, such as segmental aneuploidy and mosaicism, should be managed cautiously, considering their undermined reproductive potential.
To analyze chromosomal status in reserved multiple displacement amplification (MDA) products of embryos that result in miscarriages or live births. Of 28 embryos resulting in miscarriages in the case group, the rate of chromosomal abnormalities was 53.6%, which was significantly greater than 14.3% for those resulting in live births in control group (P < 0.001). Whole-chromosome aneuploidy was not found in the control group but was noted in 25.0% of embryos in the case group. Although the rates of segmental abnormality and mosaicism were also greater in the case group, no significant differences were detected. One chaotic embryo in the control group progressed to live birth. Chromosomal abnormalities were the main reason leading to early pregnancy loss. However, abnormalities, such as segmental aneuploidy and mosaicism, should be managed cautiously, considering their undermined reproductive potential.
To analyze chromosomal status in reserved multiple displacement amplification (MDA) products of embryos that result in miscarriages or live births. Patients who underwent preimplantation genetic testing for monogenic disorders (PGT-Ms) without aneuploidy screening were included. The case group included 28 cycles that resulted in miscarriages. Controls included 56 cycles with live births. Comprehensive chromosomal screening (CCS) using next-generation sequencing (NGS) was performed on reserved MDA products from previous blastocyst trophectoderm biopsies. The incidence and type of chromosomal abnormalities in embryos resulting in miscarriages or live births were analyzed. Of 28 embryos resulting in miscarriages in the case group, the rate of chromosomal abnormalities was 53.6%, which was significantly greater than 14.3% for those resulting in live births in control group (P < 0.001). Whole-chromosome aneuploidy was not found in the control group but was noted in 25.0% of embryos in the case group. Although the rates of segmental abnormality and mosaicism were also greater in the case group, no significant differences were detected. One chaotic embryo in the control group progressed to live birth. Chromosomal abnormalities were the main reason leading to early pregnancy loss. However, abnormalities, such as segmental aneuploidy and mosaicism, should be managed cautiously, considering their undermined reproductive potential.
Abstract Objective To analyze chromosomal status in reserved multiple displacement amplification (MDA) products of embryos that result in miscarriages or live births. Methods Patients who underwent preimplantation genetic testing for monogenic disorders (PGT-Ms) without aneuploidy screening were included. The case group included 28 cycles that resulted in miscarriages. Controls included 56 cycles with live births. Comprehensive chromosomal screening (CCS) using next-generation sequencing (NGS) was performed on reserved MDA products from previous blastocyst trophectoderm biopsies. The incidence and type of chromosomal abnormalities in embryos resulting in miscarriages or live births were analyzed. Results Of 28 embryos resulting in miscarriages in the case group, the rate of chromosomal abnormalities was 53.6%, which was significantly greater than 14.3% for those resulting in live births in control group (P < 0.001). Whole-chromosome aneuploidy was not found in the control group but was noted in 25.0% of embryos in the case group. Although the rates of segmental abnormality and mosaicism were also greater in the case group, no significant differences were detected. One chaotic embryo in the control group progressed to live birth. Conclusion Chromosomal abnormalities were the main reason leading to early pregnancy loss. However, abnormalities, such as segmental aneuploidy and mosaicism, should be managed cautiously, considering their undermined reproductive potential.
ArticleNumber 35
Audience Academic
Author Zhou, Canquan
Xu, Yanwen
Xu, Yan
Pan, Jiafu
Yang, Guoxia
Zeng, Yanhong
Guo, Jing
Author_xml – sequence: 1
  givenname: Guoxia
  surname: Yang
  fullname: Yang, Guoxia
– sequence: 2
  givenname: Yan
  surname: Xu
  fullname: Xu, Yan
– sequence: 3
  givenname: Yanhong
  surname: Zeng
  fullname: Zeng, Yanhong
– sequence: 4
  givenname: Jing
  surname: Guo
  fullname: Guo, Jing
– sequence: 5
  givenname: Jiafu
  surname: Pan
  fullname: Pan, Jiafu
– sequence: 6
  givenname: Canquan
  surname: Zhou
  fullname: Zhou, Canquan
– sequence: 7
  givenname: Yanwen
  surname: Xu
  fullname: Xu, Yanwen
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35197054$$D View this record in MEDLINE/PubMed
BookMark eNp9ktuK1TAUhouMOAd9AS8k4I2CHZO0aVMvhGHwMDAgeLgOabKyd4a0qUk6uO98Bx_Id_FJTPceh9ki0ouU1f__utbKf1wcjH6EonhM8CkhvHkZCe0oLjGlJc6FttzcK45Iy1jJ264-uPN-WBzHeIVxg1lHHhSHFSNdi1l9VPw898Mkg41-RN4gtQ5-8NEP0qGYZJojsiMKECFcg0bD7JKdHCBt4-SkggHGhOQwOWuskslmyhS8nlWKCw6GPmx8RGkt00LJ9kzJxMFGJUOwcgVZGJCz14B6G9I6vkIS9c6OGvQLlCeO4EBtyUpG-PX9h_JjCn7pb9abh8V9I12ERzfnSfHl7ZvP5-_Lyw_vLs7PLkvFmi6VRFICTWtaTSrOmO457ikAYNyZluHW1LQB0gCWPSWYar7YKkWVZF3LiKlOiosdV3t5JaZgBxk2wksrtgUfVkKGZJUD0Zq-biSvFNGmblTNO024yf-pOe0V1Zn1esea5n4ArfIOg3R70P0vo12Llb8WnDd1h1kGPLsBBP91hpjEsk9wTo7g5yhoU1FOCCVVlj7dSVcyt2ZH4zNRLXJx1nRd3VaswVl1-g9VfjQMNu8bjM31PcPzPcNyJ_AtreQco7j49HFf--TuuLdz_glhFtCdQAUfYwBzKyFYLEkXu6SLnHSxTbrYZBP_y6Rs2iYwt27d_6y_ASLlCJM
CitedBy_id crossref_primary_10_1007_s10815_023_02797_w
crossref_primary_10_1142_S2661318224500026
crossref_primary_10_1016_j_ejogrb_2024_11_003
Cites_doi 10.1016/j.fertnstert.2003.07.023
10.3390/genes11060602
10.1016/j.fertnstert.2018.10.019
10.1186/s13039-017-0315-7
10.1038/ncomms11165
10.1007/s10815-020-01720-x
10.1016/j.fertnstert.2016.08.017
10.1016/j.fertnstert.2018.08.057
10.1093/humrep/deq343
10.1016/j.fertnstert.2015.12.022
10.1093/molehr/gaaa012
10.1016/j.fertnstert.2017.09.025
10.3109/09513590.2016.1142962
10.1093/humrep/dez055
10.1093/humrep/dex324
10.1016/j.fertnstert.2009.07.989
10.1016/j.fertnstert.2020.11.041
10.1007/s10815-020-01732-7
10.1016/j.fertnstert.2007.11.044
10.1016/j.ajhg.2020.03.005
10.3390/jcm9061695
10.1093/humrep/dey327
10.1016/j.fertnstert.2021.09.008
10.1038/nrg3245
10.1093/humupd/dmz050
10.1016/j.fertnstert.2019.01.017
10.1007/s10815-011-9598-5
10.1038/s41556-021-00660-7
10.1016/j.fertnstert.2014.02.013
10.1016/j.fertnstert.2020.07.052
10.1016/j.fertnstert.2016.09.039
10.1016/j.fertnstert.2018.06.021
10.1186/1755-8166-7-46
ContentType Journal Article
Copyright 2022. The Author(s).
COPYRIGHT 2022 BioMed Central Ltd.
The Author(s) 2022
Copyright_xml – notice: 2022. The Author(s).
– notice: COPYRIGHT 2022 BioMed Central Ltd.
– notice: The Author(s) 2022
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
7X8
5PM
DOA
DOI 10.1186/s12920-022-01187-y
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic


MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1755-8794
EndPage 8
ExternalDocumentID oai_doaj_org_article_7fb46a83c1df46c489d18f9f7482bc2d
PMC8864905
A699473560
35197054
10_1186_s12920_022_01187_y
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: ;
  grantid: 2018YFC1003102
– fundername: ;
  grantid: 201704020217
– fundername: ;
  grantid: 201804020087
– fundername: ;
  grantid: 2012A061400003
GroupedDBID ---
0R~
23N
2WC
53G
5GY
5VS
6J9
7X7
88E
8AO
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACUHS
ADBBV
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
INH
INR
ISR
ITC
KQ8
LK8
M1P
M48
M7P
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
UKHRP
W2D
~8M
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7X8
PPXIY
PQGLB
5PM
PJZUB
PUEGO
ID FETCH-LOGICAL-c569t-1a21e67f7d13855db80b2eee009f7507f426e16e0ab2102d8c5693c2ca59751f3
IEDL.DBID M48
ISSN 1755-8794
IngestDate Wed Aug 27 01:27:40 EDT 2025
Thu Aug 21 14:10:38 EDT 2025
Fri Jul 11 04:04:43 EDT 2025
Tue Jun 17 21:00:35 EDT 2025
Tue Jun 10 20:08:22 EDT 2025
Fri Jun 27 04:00:44 EDT 2025
Thu Apr 03 07:08:24 EDT 2025
Tue Jul 01 02:55:38 EDT 2025
Thu Apr 24 23:10:06 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Chromosomal abnormalities
Mosaicism
Preimplantation genetic testing for monogenic disorders (PGT-Ms)
Preimplantation genetic testing for aneuploidy screening (PGT-A)
Language English
License 2022. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c569t-1a21e67f7d13855db80b2eee009f7507f426e16e0ab2102d8c5693c2ca59751f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/7fb46a83c1df46c489d18f9f7482bc2d
PMID 35197054
PQID 2632811213
PQPubID 23479
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_7fb46a83c1df46c489d18f9f7482bc2d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8864905
proquest_miscellaneous_2632811213
gale_infotracmisc_A699473560
gale_infotracacademiconefile_A699473560
gale_incontextgauss_ISR_A699473560
pubmed_primary_35197054
crossref_primary_10_1186_s12920_022_01187_y
crossref_citationtrail_10_1186_s12920_022_01187_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-02-23
PublicationDateYYYYMMDD 2022-02-23
PublicationDate_xml – month: 02
  year: 2022
  text: 2022-02-23
  day: 23
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC medical genomics
PublicationTitleAlternate BMC Med Genomics
PublicationYear 2022
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References G Xu (1187_CR32) 2014; 101
SM Maxwell (1187_CR7) 2016; 106
M Yang (1187_CR19) 2021; 23
F Spinella (1187_CR23) 2018; 109
MC Martinez (1187_CR1) 2010; 93
NR Treff (1187_CR31) 2017; 107
AR Victor (1187_CR11) 2019; 34
M Viotti (1187_CR28) 2021; 116
D Chen (1187_CR17) 2020; 37
DK Gardner (1187_CR16) 2004; 81
HH Lai (1187_CR8) 2017; 10
W Hou (1187_CR5) 2019; 111
R Orvieto (1187_CR9) 2016; 32
NM Sachdev (1187_CR10) 2020; 37
M Viotti (1187_CR29) 2021; 115
E Dimitriadou (1187_CR30) 2014; 7
L Girardi (1187_CR20) 2020; 106
PY Lin (1187_CR26) 2020
S Baba (1187_CR33) 2011; 26
M Viotti (1187_CR2) 2020
D Babariya (1187_CR21) 2017; 32
M Vera-Rodriguez (1187_CR6) 2016; 105
T Zore (1187_CR25) 2019; 111
AR Victor (1187_CR27) 2019; 111
M Popovic (1187_CR13) 2020; 26
SI Nagaoka (1187_CR3) 2012; 13
AW Tiegs (1187_CR12) 2021; 115
R Navratil (1187_CR22) 2020; 26
X Shen (1187_CR15) 2011; 28
SA Neal (1187_CR4) 2018; 110
H Bolton (1187_CR24) 2016; 7
Z Ren (1187_CR14) 2009; 91
B Lawrenz (1187_CR18) 2019; 34
References_xml – volume: 81
  start-page: 551
  issue: 3
  year: 2004
  ident: 1187_CR16
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2003.07.023
– year: 2020
  ident: 1187_CR2
  publication-title: Genes (Basel)
  doi: 10.3390/genes11060602
– volume: 111
  start-page: 280
  issue: 2
  year: 2019
  ident: 1187_CR27
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2018.10.019
– volume: 10
  start-page: 14
  year: 2017
  ident: 1187_CR8
  publication-title: Mol Cytogenet
  doi: 10.1186/s13039-017-0315-7
– volume: 7
  start-page: 11165
  year: 2016
  ident: 1187_CR24
  publication-title: Nat Commun
  doi: 10.1038/ncomms11165
– volume: 37
  start-page: 559
  issue: 3
  year: 2020
  ident: 1187_CR10
  publication-title: J Assist Reprod Genet
  doi: 10.1007/s10815-020-01720-x
– volume: 106
  start-page: 1414
  issue: 6
  year: 2016
  ident: 1187_CR7
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2016.08.017
– volume: 111
  start-page: 69
  issue: 1
  year: 2019
  ident: 1187_CR25
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2018.08.057
– volume: 26
  start-page: 466
  issue: 2
  year: 2011
  ident: 1187_CR33
  publication-title: Hum Reprod
  doi: 10.1093/humrep/deq343
– volume: 105
  start-page: 1047
  issue: 4
  year: 2016
  ident: 1187_CR6
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2015.12.022
– volume: 26
  start-page: 269
  issue: 4
  year: 2020
  ident: 1187_CR22
  publication-title: Mol Hum Reprod
  doi: 10.1093/molehr/gaaa012
– volume: 109
  start-page: 77
  issue: 1
  year: 2018
  ident: 1187_CR23
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2017.09.025
– volume: 32
  start-page: 506
  issue: 6
  year: 2016
  ident: 1187_CR9
  publication-title: Gynecol Endocrinol
  doi: 10.3109/09513590.2016.1142962
– volume: 34
  start-page: 998
  issue: 6
  year: 2019
  ident: 1187_CR18
  publication-title: Hum Reprod
  doi: 10.1093/humrep/dez055
– volume: 32
  start-page: 2549
  issue: 12
  year: 2017
  ident: 1187_CR21
  publication-title: Hum Reprod
  doi: 10.1093/humrep/dex324
– volume: 93
  start-page: 289
  issue: 1
  year: 2010
  ident: 1187_CR1
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2009.07.989
– volume: 115
  start-page: 1212
  issue: 5
  year: 2021
  ident: 1187_CR29
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2020.11.041
– volume: 37
  start-page: 549
  issue: 3
  year: 2020
  ident: 1187_CR17
  publication-title: J Assist Reprod Genet
  doi: 10.1007/s10815-020-01732-7
– volume: 91
  start-page: 359
  issue: 2
  year: 2009
  ident: 1187_CR14
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2007.11.044
– volume: 106
  start-page: 525
  issue: 4
  year: 2020
  ident: 1187_CR20
  publication-title: Am J Hum Genet
  doi: 10.1016/j.ajhg.2020.03.005
– year: 2020
  ident: 1187_CR26
  publication-title: J Clin Med
  doi: 10.3390/jcm9061695
– volume: 34
  start-page: 181
  issue: 1
  year: 2019
  ident: 1187_CR11
  publication-title: Hum Reprod
  doi: 10.1093/humrep/dey327
– volume: 116
  start-page: 1212
  issue: 5
  year: 2021
  ident: 1187_CR28
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2021.09.008
– volume: 13
  start-page: 493
  issue: 7
  year: 2012
  ident: 1187_CR3
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg3245
– volume: 26
  start-page: 313
  issue: 3
  year: 2020
  ident: 1187_CR13
  publication-title: Hum Reprod Update
  doi: 10.1093/humupd/dmz050
– volume: 111
  start-page: 928
  issue: 5
  year: 2019
  ident: 1187_CR5
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2019.01.017
– volume: 28
  start-page: 957
  issue: 10
  year: 2011
  ident: 1187_CR15
  publication-title: J Assist Reprod Genet
  doi: 10.1007/s10815-011-9598-5
– volume: 23
  start-page: 314
  issue: 4
  year: 2021
  ident: 1187_CR19
  publication-title: Nat Cell Biol
  doi: 10.1038/s41556-021-00660-7
– volume: 101
  start-page: 1663
  issue: 6
  year: 2014
  ident: 1187_CR32
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2014.02.013
– volume: 115
  start-page: 627
  issue: 3
  year: 2021
  ident: 1187_CR12
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2020.07.052
– volume: 107
  start-page: 27
  issue: 1
  year: 2017
  ident: 1187_CR31
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2016.09.039
– volume: 110
  start-page: 896
  issue: 5
  year: 2018
  ident: 1187_CR4
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2018.06.021
– volume: 7
  start-page: 46
  year: 2014
  ident: 1187_CR30
  publication-title: Mol Cytogenet
  doi: 10.1186/1755-8166-7-46
SSID ssj0060591
Score 2.2934926
Snippet To analyze chromosomal status in reserved multiple displacement amplification (MDA) products of embryos that result in miscarriages or live births. Patients...
To analyze chromosomal status in reserved multiple displacement amplification (MDA) products of embryos that result in miscarriages or live births. Of 28...
Objective To analyze chromosomal status in reserved multiple displacement amplification (MDA) products of embryos that result in miscarriages or live births....
To analyze chromosomal status in reserved multiple displacement amplification (MDA) products of embryos that result in miscarriages or live births.OBJECTIVETo...
Abstract Objective To analyze chromosomal status in reserved multiple displacement amplification (MDA) products of embryos that result in miscarriages or live...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 35
SubjectTerms Abortion, Spontaneous - genetics
Abortion, Spontaneous - pathology
Aneuploidy
Blastocyst - pathology
Case studies
Case-Control Studies
Chromosomal abnormalities
Chromosomes
Embryonic development
Female
Genetic aspects
Genetic Testing - methods
Health aspects
Humans
Live Birth
Miscarriage
Mosaicism
Patient outcomes
Pregnancy
Preimplantation Diagnosis - methods
Preimplantation genetic testing for aneuploidy screening (PGT-A)
Preimplantation genetic testing for monogenic disorders (PGT-Ms)
SummonAdditionalLinks – databaseName: Directory of Open Access Journals (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQD4gL4p-UggxC4gBR107iONxKRVWQygGo1Jvl3-5K26RKskh74x14IN6FJ2HGya42QoIL1_XYu7a_eMbZb74h5KXTAfyY9KmJKTlSh9SIQmOCj-cOInQpMVH47JM4Pc8_XhQXO6W-kBM2yAMPC3dYBpMLLTPLXMiFzWXlmAxVKHPJjeUOT1_weZvL1HAGQ4xesU2KjBSHHcOiTCky12N97XQ9cUNRrf_PM3nHKU0Jkzse6OQOuT2GjvRo-Ml3yQ1f3yM3z8Y_x--Tn8fbmoK0CdTOkWnXNVfQB9OGVh1d1BSzjdpv3tENk5C6RReJWfiakGokmIfxPR69HuRgOxzOX5l23XS0n-seR4HuMAqMCECxugUcX3owbOkSzk9qFm0_795STc0SBRndG1ojb3sZmV81teA8f33_MRLlaRS5fUDOT95_PT5Nx_oMqS1E1adMc-ZFGUrHMlkUzsiZ4d57CNsCBCJlAO_vmfAzbfBi6SR2yyy3Gm4xBQvZQ7IH3-0fEyoLA_coaT1E0bn3orKBOwHwKoPmZcETwjbbpewoXo41NJYqXmKkUMMWK9hiFbdYrRPyetvnepDu-Kv1O0TB1hJlt-MHAEY1glH9C4wJeYEYUiisUSNz51Kvuk59-PJZHYmqwjLPYpaQV6NRaGAOVo-JELASqMU1sTyYWOKGTpqfb6CqsAnpcrVvVp1CEX7JUK0vIY8G6G4nhhUZSwjUE1JOQD2Z-bSlXsyj8LiUIq9mxf7_WKon5BaPzyNPeXZA9vp25Z9CfNebZ_FR_g3UVVQA
  priority: 102
  providerName: Directory of Open Access Journals
Title Comparison of chromosomal status in reserved multiple displacement amplification products of embryos that resulted in miscarriages or live births: a blinded, nonselection case–control study
URI https://www.ncbi.nlm.nih.gov/pubmed/35197054
https://www.proquest.com/docview/2632811213
https://pubmed.ncbi.nlm.nih.gov/PMC8864905
https://doaj.org/article/7fb46a83c1df46c489d18f9f7482bc2d
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ta9swEBZ9gbEvY-_z1gVtDPZh8xY7tiwPxkhLSxdIGe0C_Sb0mgRSu7Odsfy4_bfdKU6oWRn7FLBOCrJOujv57nkIeWOkAzvGbah8SQ6XLlQslVjgY2MDHjrnWCg8PmOnk2R0mV7ukA3dUfsC61tDO-STmlSLD79-rL7Ahv_sNzxnH-sIKZdCzEv37Nnhapfsg2XKkMphnGy_KoDn7hn0wGKmcArkyaaI5tYxOobK4_n_fWrfMFvdlMobNurkPrnXOpd0uNaGB2THFg_JnXH7-fwR-X20ZR2kpaN6hrl4dXkFfbCwaFnTeUGxHqn6aQ3d5BpSM6996hZeJFKJKeiuvemj12vA2BqHs1eqWpU1bWaywVGgO4wCI4IqaVmBpk8tCFZ0AScsVfOqmdWfqKRqgZCN5j0tMLN74XPDCqrBvIZtIj31ILiPyeTk-PvRadjyN4Q6ZXkTRjKOLMtcZqIBT1OjeF_F1lpw6xw4KpkD78BGzPalwsDTcOw20LGWEOWkkRs8IXvwz_YZoTxVEGdxbcHLTqxluXaxYaB-mZNxlsYBiTaLJXQLbo4cGwvhgxzOxHqBBSyw8AssVgF5t-1zvYb2-Kf0IerAVhJhuf2DspqKdpeLzKmEST7QkXEJ0wnPTcQdzDbhsdKxCchr1CCBwBsFZvZM5bKuxdeLczFkeY400KwfkLetkCthDlq2hRLwJhCrqyN50JHE5ew0v9ooqsAmTKcrbLmsBYL08wjR_ALydK2424khY2MGjnxAso5Kd2bebSnmMw9MzjlL8n76_L8n8ILcjf2Wi8N4cED2mmppX4KT16ge2c0usx7ZHw5HFyP4PTw--3be81cmPb-r_wDvFVeS
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+chromosomal+status+in+reserved+multiple+displacement+amplification+products+of+embryos+that+resulted+in+miscarriages+or+live+births%3A+a+blinded%2C+nonselection+case-control+study&rft.jtitle=BMC+medical+genomics&rft.au=Yang%2C+Guoxia&rft.au=Xu%2C+Yan&rft.au=Zeng%2C+Yanhong&rft.au=Guo%2C+Jing&rft.date=2022-02-23&rft.pub=BioMed+Central+Ltd&rft.issn=1755-8794&rft.eissn=1755-8794&rft.volume=15&rft.issue=1&rft_id=info:doi/10.1186%2Fs12920-022-01187-y&rft.externalDocID=A699473560
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1755-8794&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1755-8794&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1755-8794&client=summon